Zhijun Zhou

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 8

Top Topics

Mass Spectrometry

Long Noncoding Rna

Cancer Stem Cells

Top Venues

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Tianfu Yu, Fengqi Zhou, Wei Tian, Ran Xu, Binbin Wang, Ailiang Zeng, Zhijun Zhou, Min Li, Yingyi Wang, Junxia Zhang
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene 42 (6) (2022)
Tianfu Yu, Fengqi Zhou, Wei Tian, Ran Xu, Binbin Wang, Ailiang Zeng, Zhijun Zhou, Min Li, Yingyi Wang, Junxia Zhang
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene (2022)
Tianfu Yu, Fengqi Zhou, Wei Tian, Ran Xu, Binbin Wang, Ailiang Zeng, Zhijun Zhou, Min Li, Yingyi Wang, Junxia Zhang
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene 42 (6) (2022)
Tianfu Yu, Fengqi Zhou, Wei Tian, Ran Xu, Binbin Wang, Ailiang Zeng, Zhijun Zhou, Min Li, Yingyi Wang, Junxia Zhang
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene 42 (6) (2022)
Tianfu Yu, Fengqi Zhou, Wei Tian, Ran Xu, Binbin Wang, Ailiang Zeng, Zhijun Zhou, Min Li, Yingyi Wang, Junxia Zhang
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene 42 (6) (2022)
Tianfu Yu, Fengqi Zhou, Wei Tian, Ran Xu, Binbin Wang, Ailiang Zeng, Zhijun Zhou, Min Li, Yingyi Wang, Junxia Zhang
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Oncogene 42 (6) (2022)
Zhen Xiang, Zhijun Zhou, Shuzheng Song, Jun Li, Jun Ji, Ranlin Yan, Jiexuan Wang, Wei Cai, Wenjun Hu, Lu Zang, Zhenggang Zhu, Zhen Zhang, Min Li, Yingyan Yu
Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways. Oncogene 40 (31) (2021)
Qiangsheng Hu, Yi Qin, Shunrong Ji, Xiuhui Shi, Weixing Dai, Guixiong Fan, Shuo Li, Wenyan Xu, Wensheng Liu, Mengqi Liu, Zheng Zhang, Zeng Ye, Zhijun Zhou, Guangchao Yang, Qifeng Zhuo, Xianjun Yu, Min Li, Xiaowu Xu
MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Cancer research 81 (19) (2021)